NCT07636590ClinicalTrials.gov
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
En resumen
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Observacional500 participantes buscados21 centros1 país
Categorías
Registrado en 1 registro
- ClinicalTrials.govNCT07636590Abrir este registro en ClinicalTrials.govSincronizado anteayer
Un mismo estudio puede estar registrado en varios registros. Lo mostramos una sola vez y enlazamos con todos los registros que tenemos.
La información del ensayo se muestra tal como la publicó el registro, en su idioma original.
¿Le interesa este estudio?
Iniciar sesión o cree una cuenta para registrar su interés y seguir este estudio.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 18 days after the recorded start)First posted 2026-06-09; recorded start 2026-05-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Claris Biotherapeutics, Inc.)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration3/5
Registered within 30 days of the study start
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 500 participants (target), run at 21 sites.
How this score is built
- Enrolment26/40
500 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration7/10
Planned over about 22 months
- Sponsor scale1/10
Claris Biotherapeutics, Inc. has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Resumen
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Afecciones
- Limbal Stem Cell Deficiency
Elegibilidad
| Sexo | Todos |
|---|---|
| Edades | 12 Years – 99 Years |
| Voluntarios sanos | No |
| Método de muestreo | PROBABILITY_SAMPLE |
Población del estudio
Adult and adolescent subjects with qualifying LSCD
Elegibilidad tal como figura en el registro
Elegibilidad en frases sencillas
Los criterios de este registro aún no se han desglosado en frases separadas. El texto del registro anterior está completo y es la versión autorizada.
Diseño del estudio
| Tipo de estudio | Observacional |
|---|---|
| Fase | No indicado en el registro |
| Asignación | No indicado en el registro |
| Modelo de intervención | No indicado en el registro |
| Propósito principal | No indicado en el registro |
| Enmascaramiento | No indicado en el registro |
| Inscripción | 500 participantes buscados |
Patrocinador y colaboradores
- Claris Biotherapeutics, Inc. Patrocinador
Grupos e intervenciones
- Non-interventional
No product administration.
Intervenciones
- Otro Non-interventional
Non-interventional
Variables de resultado
Variable de resultado principal
Natural Progression of LSCD as Assessed by Changes in Patient Reported Outcomes
Onset or changes (worsening or improving) in vision-related quality of life and ocular symptoms as captured with the National Eye Institute Visual Function Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI) questionnaires
Plazo Screening through Week 84
Variable de resultado principal
Natural Progression of LSCD as Assessed by Functional Changes (Photophobic BCVA)
Change in photophobic BCVA
Plazo Screening through Week 84
Variable de resultado principal
Natural Progression of LSCD as Assessed by Functional Changes (Low-luminance BCVA)
Change in low-luminance BCVA
Plazo Screening through Week 84
Variable de resultado principal
Natural Progression of LSCD as Assessed by Functional Changes (Low-contrast BCVA)
Change in low-contrast BCVA
Plazo Screening through Week 84
Variable de resultado principal
Natural Progression of LSCD as Assessed by Functional Changes (Contrast Sensitivity)
Change in contrast sensitivity (Pelli-Robson)
Plazo Screening through Week 84
Variable de resultado principal
Natural Progression of LSCD as Assessed by Anatomical/Structural Changes
Change in area of central cornea conjunctivalization
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Functional Changes (Corneal Sensitivity)
Changes (onset, improvement, or worsening) in corneal sensitivity
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Corneal Topography/Tomography)
Changes (onset, improvement, or worsening) in corneal topography and/or tomography and/or densitometry
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial Defect Frequency)
Changes (onset, improvement, or worsening) in epithelial defect frequency
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Palisades of Vogt Crypts)
Changes (onset, improvement, or worsening) in Palisades of Vogt crypts
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial and Total Corneal Thickness)
Changes (onset, improvement, or worsening) in epithelial and total corneal thickness
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Pannus)
Changes (onset, improvement, or worsening) in pannus
Plazo Screening through Week 84
Variable de resultado secundaria
Changes that May be Correlated with LSCD as Assessed by Changes Ocular and Systemic Health Outcome Measures
Changes (onset, improvement/resolution, or worsening) of an existing condition
Plazo Screening through Week 84
Fechas
| Fecha de inicio | 22 de mayo de 2026 (real) |
|---|---|
| Finalización principal | 1 de marzo de 2028 (estimada) |
| Finalización | 1 de marzo de 2028 (estimada) |
| Primera publicación | 9 de junio de 2026 (real) |
| Última actualización | 18 de noviembre de 2026 |
| Resultados publicados | No indicado en el registro |
| Estado verificado por última vez | noviembre de 2026 |
Real significa que el evento ocurrió. Estimada significa que el patrocinador lo prevé. Ambas cosas significan algo distinto.
Ubicaciones
21 centros están en reclutamiento
United States
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Claris Investigative Site | Carmel | Indiana | En reclutamiento |
| Claris Investigative Site | Cranberry Township | Pennsylvania | En reclutamiento |
| Claris Investigative Site | Draper | Utah | En reclutamiento |
| Claris Investigative Site | Huntington Beach | California | En reclutamiento |
| Claris Investigative Site | Indianapolis | Indiana | En reclutamiento |
| Claris Investigative Site | Kansas City | Missouri | En reclutamiento |
| Claris Investigative Site | La Jolla | California | En reclutamiento |
| Claris Investigative Site | Los Angeles | California | En reclutamiento |
| Claris Investigative Site | Louisville | Kentucky | En reclutamiento |
| Claris Investigative Site | Minnetonka | Minnesota | En reclutamiento |
| Claris Investigative Site | Norfolk | Virginia | En reclutamiento |
| Claris Investigative Site | Overland Park | Kansas | En reclutamiento |
| Claris Investigative Site | Palisades Park | New Jersey | En reclutamiento |
| Claris Investigative Site | Portland | Oregon | En reclutamiento |
| Claris Investigative Site | Rockville Centre | New York | En reclutamiento |
| Claris Investigative Site | San Antonio | Texas | En reclutamiento |
| Claris Investigative Site | Sioux Falls | South Dakota | En reclutamiento |
| Claris Investigative Site | Smyrna | Tennessee | En reclutamiento |
| Claris Investigative Site | South Dartmouth | Massachusetts | En reclutamiento |
| Claris Investigative Site | Tampa | Florida | En reclutamiento |
| Claris Investigative Site | Wichita | Kansas | En reclutamiento |
Documentos del estudio
No hay documentos enlazados en este registro.
Cambios a lo largo del tiempo
- 18 de noviembre de 2026
Centro añadido
13 sites added (21 total)
821
- 6 de agosto de 2026
Centro añadido
6 sites added (8 total)
28